Marissa J. Perman-Laskin, MD
Professor of Clinical Pediatrics (General Pediatrics)
Attending Physician, Hospital of the University of Pennsylvania,
Neonatology
Attending Physician, Children's Hospital of Philadelphia
Clinic Director, Section of Dermatology, Children's Hospital of Philadelphia
Director, Epidermolysis Bullosa Multidisciplinary Clinic, Children's Hospital of Philadelphia
Section Chief, Section of Dermatology, Children's Hospital of Philadelphia
Phototherapy Director, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
3500 Civic Center Boulevard
Dermatology Section
Philadelphia, PA 19104
3500 Civic Center Boulevard
Dermatology Section
Philadelphia, PA 19104
Office: 215-590-2169
Fax: 215-590-4948
Fax: 215-590-4948
Education:
BA (Near Eastern Studies)
Cornell University, 1999.
MD
University of Maryland School of Medicine, 2005.
Permanent linkBA (Near Eastern Studies)
Cornell University, 1999.
MD
University of Maryland School of Medicine, 2005.
Description of Clinical Expertise
Sunscreen SafetyEpidermolysis Bullosa
Hemangiomas
Atopic Dermatitis
Acne Vulgaris
PCOS
Sports Dermatology
Description of Research Expertise
Epidermolysis bullosaSelected Publications
Afnan Albahri, MD; Marissa Perman, MD; Meghan Galligan, MD MSHP: Acute Hospitalization Patterns of Epidermolysis Bullosa Patients at a Children's Hospital. PAS, Toronto, Canada May 2024.Huang CY, Perman MJ, Yan AC.: Regimen for accelerated propranolol initial dosing (RAPID). Pediatr Dermatol Apr 2024.
Abreu Molnar B, Levin L, Yun D, Morel K, Wiss K, Wieser J, Ward C, Trice H, Garcia-Romero MT, Stephenson A, Provost A, Price HN, Perman MJ, Moxon M, Moeves B, McCuaig CC, McCarthy C, Lucky AW, Levy ML, Lee M, Lara-Corrales I, Henner N, Halliburton N, Griffith E, Gorell E, Glick S, Eichenfield L, Collins C, Bruckner AL, Boulrice B, Bayliss S, Badger K, Paller AS.: Inpatient management of epidermolysis bullosa: Consensus-based hands-on instructions for neonates and postneonates. J Am Acad Dermatol Apr 2024.
Hannah Seay, MD, Marissa Perman, MD, James Treat, MD, Fahad Ahmed BA, Terri Brown-Whitehorn, MD, Jonathan Spergel, MD, PhD, Jennifer Heimall, MD: MMR and Varicella Immunization Rate During Dupilumab Therapy 2024 AAAAI Annual Meeting, Washington, DC Feb 2024.
Ahmed F, Fisher MJ, Snyder KM, Smith K, Laskin BL, Perman MJ.: Adverse cutaneous reactions associated with MEK inhibitor therapy in a pediatric population. J Am Acad Dermatol Nov 2023.
Hannah Seay, MD1, Marissa Perman, MD, James Treat, MD, Fahad Ahmed BA, Terri Brown-Whitehorn, MD, Jonathan Spergel, MD, PhD, Jennifer Heimall, MD: MMR and Varicella Immunization During Dupilumab Therapy. ACAAI 2023 Annual Scientific Meeting, Anaheim, CA Nov 2023.
Shane Swink, DO, Supra Rastogi, MD, Marissa Perman, MD: A Pair of Systematized Linear Porokeratoses Treated with Topical Cholesterol/Lovastatin. Society for Pediatric Dermatology Annual Meeting, Asheville, NC July 2023 Notes: Poster (Cases of the Year).
Hannah E. Myers, BS and Marissa Perman, MD: Junctional Epidermolysis Bulls due to LAMB3 Mutations in Skin of Color. Society for Pediatric Dermatology Annual Meeting, Asheville, NC July 2023 Notes: Poster (Cases of the Year).
Charles Y. Hang, Marissa J. Perman, MD, Albert C. Yan, MD: Regimen for Accelerated Propranolol Initial Dosing (RAPID). Society for Pediatric Dermatology Annual Meeting, Asheville, NC July 2023 Notes: Poster (Cases of the Year).
Larijani M, Zarowin D, Wohlschlaeger A, Perman MJ, Treat JR.: Atopic dermatitis-like graft-versus-host disease treated with dupilumab. Pediatr Dermatol 40(2): 320-322, Mar 2023.